Nouvelles de la Bourse
Dernières actualités financières · Mis à jour Mai 23, 2026
Charles Schwab (SCHW) lance des comptes pour adolescents investisseurs
Charles Schwab (SCHW) Launches Teen Investor Accounts
The panel is divided on Schwab's (SCHW) recent strategies. While some see the 'Teen Investor' accounts and Forge Global acquisition …
Wolfe Research améliore Brinker International (EAT) à Surperformance
Wolfe Research Upgrades Brinker International (EAT) to Outperform
Analyst upgrades on EAT reflect recent traffic outperformance, but high leverage and reliance on promotions pose significant risks. A consensus …
Carvana grimpe alors que Jefferies signale une forte croissance des unités et une dynamique des prix
Carvana surges as Jefferies flags strong unit growth, pricing momentum
The panelists' discussion reveals a mixed sentiment towards Carvana's recent performance, with inventory deceleration and potential liquidity constraints being the …
Les prix du pétrole brut reculent sur l'espoir que la guerre en Iran touche à sa fin
Crude Oil Prices Retreat on Hopes the Iran War is Near an End
Despite headlines suggesting a 'de-escalation premium', the panel agrees that structural supply disruptions persist, with the Strait of Hormuz remaining …
La fintech de MercadoLibre renonce à sa cryptomonnaie Mercado Coin
MercadoLibre's fintech terminates its cryptocurrency Mercado Coin
MercadoLibre's shift from Mercado Coin to Meli Dolar is seen as a strategic pivot towards a more useful financial tool, …
Apellis Pharma s'envole suite à l'accord avec Biogen. Est-il trop tard pour acheter des actions APLS ?
Apellis Pharma Skyrockets on Biogen Deal. Is It Too Late to Chase APLS Stock?
The panel is largely bearish on the APLS-BIIB deal, citing regulatory risks, overpayment concerns, integration challenges, and potential drug issues. …
Prévisions sur l'action Carnival : des vents contraires maintenant, une hausse à venir ?
Carnival Stock Forecast: Headwinds Now, Upside Ahead?
The panel's net takeaway is that while Carnival's (CCL) strong booking visibility and capital return ambitions argue for upside, the …
Les traders d'options s'intéressent à une action pharmaceutique après le rachat par Eli Lilly
Options Traders Pick Up Pharma Stock After Eli Lilly Buyout
The panel is divided on the CNTA-LLY acquisition, with concerns about deal risk, overpayment, and clinical execution risk for orexin …
Verdict de 2 milliards de dollars pour Bayer : ce que la décision sur le Roundup signifie pour MAHA
$2 Billion Bayer Verdict: What the Roundup Decision Means for MAHA
Bayer's financial future hinges on the Supreme Court's decision in Monsanto v. Durnell, which could either collapse the remaining 65,000 …
Tesla en hausse de 5 % : les espoirs de livraison du T1, Terafab et le buzz de SpaceX convergent tous en même temps
Tesla Surges 5%: Delivery Hopes, Terafab, and SpaceX Buzz Are All Converging at Once
The panelists agreed that Tesla's recent rally is driven by narrative stacking, but they expressed concerns about sequential delivery declines, …
Faut-il suivre le rally de Marvell déclenché par Nvidia aujourd'hui ?
Should You Chase the Nvidia-Triggered Rally in Marvell Stock Today?
The panel is neutral on Marvell (MRVL) following Nvidia's $2B investment, with concerns around revenue attribution, execution risk, and potential …
Skanska cède la propriété de l'I-4 Ultimate
Skanska Divests Ownership Of I-4 Ultimate
Skanska's sale of its 50% stake in I-4 Mobility Partners HoldCo for $75M appears to be a strategic capital recycling …